Keefe T Chan
7PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer.Carmelo Cerra, Madeleine R C Tancock, Niko Thio
|Dec 04, 2023
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors.Catherine Dietrich, Alec Trub, Antonio Ahn
|Jun 27, 2022
Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation.Haoran Zhu, Keefe T Chan, Xinran Huang
|Nov 11, 2020
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.Shunfei Yan, Jiachen Xuan, Natalie Brajanovski
|Sep 18, 2020
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis.Eric P Kusnadi, Anna S Trigos, Carleen Cullinane
|May 28, 2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer.Elaine Sanij, Katherine M Hannan, Jiachen Xuan
Pageof 2
Frequent Collaborators
6 joint publications
Richard B Pearson
3 joint publications
Ross D Hannan
3 joint publications
Elaine Sanij
3 joint publications
Anna S Trigos
3 joint publications
Carleen Cullinane
3 joint publications
Jian Kang
2 joint publications
Katherine M Hannan
2 joint publications
Sarah Ellis
2 joint publications
Karen E Sheppard
1 joint publications
Olga Kondrashova
